Miscellaneous News

RSS
Designer SARS-CoV-2 RBD vaccine produces dramatically improved antibody response in preclinical trials

Designer SARS-CoV-2 RBD vaccine produces dramatically improved antibody response in preclinical trials

Huge healthcare burden of post-COVID-19 symptoms likely, suggests new study

Huge healthcare burden of post-COVID-19 symptoms likely, suggests new study

T cell populations in nasal mucosa expand after COVID-19 mRNA vaccination

T cell populations in nasal mucosa expand after COVID-19 mRNA vaccination

Study reveals acute immunologic changes in children with long COVID

Study reveals acute immunologic changes in children with long COVID

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

Case study describes consequences of undetected SARS-CoV-2 infection during mRNA vaccination

Case study describes consequences of undetected SARS-CoV-2 infection during mRNA vaccination

Research suggests Pfizer-BioNTech COVID-19 vaccine reprograms innate immune responses

Research suggests Pfizer-BioNTech COVID-19 vaccine reprograms innate immune responses

Scientists produce a universal flu vaccine using nanoparticles to induce long-lasting immunity

Scientists produce a universal flu vaccine using nanoparticles to induce long-lasting immunity

Preclinical study finds sex differences in neurological response to SARS-CoV-2 infection

Preclinical study finds sex differences in neurological response to SARS-CoV-2 infection

Study identifies most persistent neurological problems during long COVID-19

Study identifies most persistent neurological problems during long COVID-19

New nanoimmunoassay can detect anti–SARS-CoV-2 antibodies in ultralow-volume blood samples

New nanoimmunoassay can detect anti–SARS-CoV-2 antibodies in ultralow-volume blood samples

Pfizer-BioNTech mRNA vaccine reduces both symptomatic and asymptomatic COVID-19 infection in case study

Pfizer-BioNTech mRNA vaccine reduces both symptomatic and asymptomatic COVID-19 infection in case study

How did SARS-CoV-2 first evolve in humans?

How did SARS-CoV-2 first evolve in humans?

Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants

Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants

Human organoids useful for modeling COVID-19 variants of concern, finds study

Human organoids useful for modeling COVID-19 variants of concern, finds study

Unemployed Australian citizens experience mental health deterioration during COVID-19 pandemic, finds study

Unemployed Australian citizens experience mental health deterioration during COVID-19 pandemic, finds study

Aberrant immune features in healthy elderly and male subjects with severe COVID-19 may predate infection

Aberrant immune features in healthy elderly and male subjects with severe COVID-19 may predate infection

Researchers develop a multivalent vaccine for COVID-19 and influenza

Researchers develop a multivalent vaccine for COVID-19 and influenza

Nanoparticle (SpFN) vaccine candidate elicits multifactorial cellular immune responses against SARS-CoV-2 in vivo

Nanoparticle (SpFN) vaccine candidate elicits multifactorial cellular immune responses against SARS-CoV-2 in vivo

Researchers identify mechanism of platelet hyperactivation in COVID-19 patients

Researchers identify mechanism of platelet hyperactivation in COVID-19 patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.